Listar por autor "Azcue Sanromán, Pablo"
Mostrando ítems 1-4 de 4
-
A novel prognostic biomarker panel for early‐stage colon carcinoma
Azcue Sanromán, Pablo; Guerrero Setas, David; Encío Martínez, Ignacio
; Ibáñez Beroiz, B. ; Mercado Gutiérrez, María R.; Vera García, Ruth; Gómez Dorronsoro, María Luisa (MDPI, 2021)
Artículo / Artikulua 
Molecular characterization of colorectal cancer has helped us understand better the biology of the disease. However, previous efforts have yet to provide significant clinical value in order to be integrated into clinical ... -
PD-L1 as a prognostic factor in early-stage colon carcinoma within the immunohistochemical molecular subtype classification
Azcue Sanromán, Pablo; Encío Martínez, Ignacio ; Guerrero Setas, David; Suárez Alecha, Javier; Galbete Jiménez, Arkaitz ; Mercado Gutiérrez, María R.; Vera García, Ruth; Gómez Dorronsoro, María Luisa (MDPI, 2021)
Artículo / Artikulua
Colorectal cancer (CRC) is a very heterogeneous disease. Efforts to characterize and search for biomarkers for these patients are currently ongoing in the hope of establishing a more targeted therapeutic approach. The role ... -
Research of immunohistochemical biomarkers and Consensus Molecular Subtypes to characterize early-stage colorectal cancer patients
(2022) Tesis doctoral / Doktoretza tesiaEl trabajo de investigación llevado a cabo en esta tesis doctoral tiene como principal objetivo una mejor caracterización de los pacientes con cáncer de colon en estadios tempranos (estadio II y III). A pesar de que existen ... -
ZEB1 hypermethylation is associated with better prognosis in patients with colon cancer
(BMC, 2023) Artículo / Artikulua
Background: Colon cancer (CC) is a heterogeneous disease that is categorized into four Consensus Molecular Subtypes (CMS) according to gene expression. Patients with loco-regional CC (stages II/III) lack prognostic factors, ...
